Association of PCSK9 inhibitors with bone disease: A comprehensive drug-target Mendelian randomization study
Wangyu Yang, Xiaohui Wang, Hao Yang, Dingjun Hao
This study uses Mendelian randomization to investigate the causal relationship between PCSK9 inhibitors and bone diseases, finding mixed effects on osteoporosis, osteoarthritis, and rheumatoid arthritis.
Journal of Contemporary Medical Practice · May 29, 2025Peer-reviewedGenetic & Genomic Medicine